Cargando…
Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design
MOTIVATION: The process of placing new drugs into the market is time-consuming, expensive and complex. The application of computational methods for designing molecules with bespoke properties can contribute to saving resources throughout this process. However, the fundamental properties to be optimi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336597/ https://www.ncbi.nlm.nih.gov/pubmed/34252946 http://dx.doi.org/10.1093/bioinformatics/btab301 |
_version_ | 1783733352532017152 |
---|---|
author | Pereira, Tiago Abbasi, Maryam Oliveira, José Luis Ribeiro, Bernardete Arrais, Joel |
author_facet | Pereira, Tiago Abbasi, Maryam Oliveira, José Luis Ribeiro, Bernardete Arrais, Joel |
author_sort | Pereira, Tiago |
collection | PubMed |
description | MOTIVATION: The process of placing new drugs into the market is time-consuming, expensive and complex. The application of computational methods for designing molecules with bespoke properties can contribute to saving resources throughout this process. However, the fundamental properties to be optimized are often not considered or conflicting with each other. In this work, we propose a novel approach to consider both the biological property and the bioavailability of compounds through a deep reinforcement learning framework for the targeted generation of compounds. We aim to obtain a promising set of selective compounds for the adenosine [Formula: see text] receptor and, simultaneously, that have the necessary properties in terms of solubility and permeability across the blood–brain barrier to reach the site of action. The cornerstone of the framework is based on a recurrent neural network architecture, the Generator. It seeks to learn the building rules of valid molecules to sample new compounds further. Also, two Predictors are trained to estimate the properties of interest of the new molecules. Finally, the fine-tuning of the Generator was performed with reinforcement learning, integrated with multi-objective optimization and exploratory techniques to ensure that the Generator is adequately biased. RESULTS: The biased Generator can generate an interesting set of molecules, with approximately 85% having the two fundamental properties biased as desired. Thus, this approach has transformed a general molecule generator into a model focused on optimizing specific objectives. Furthermore, the molecules’ synthesizability and drug-likeness demonstrate the potential applicability of the de novo drug design in medicinal chemistry. AVAILABILITY AND IMPLEMENTATION: All code is publicly available in the https://github.com/larngroup/De-Novo-Drug-Design. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-8336597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83365972021-08-09 Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design Pereira, Tiago Abbasi, Maryam Oliveira, José Luis Ribeiro, Bernardete Arrais, Joel Bioinformatics Biomedical Informatics MOTIVATION: The process of placing new drugs into the market is time-consuming, expensive and complex. The application of computational methods for designing molecules with bespoke properties can contribute to saving resources throughout this process. However, the fundamental properties to be optimized are often not considered or conflicting with each other. In this work, we propose a novel approach to consider both the biological property and the bioavailability of compounds through a deep reinforcement learning framework for the targeted generation of compounds. We aim to obtain a promising set of selective compounds for the adenosine [Formula: see text] receptor and, simultaneously, that have the necessary properties in terms of solubility and permeability across the blood–brain barrier to reach the site of action. The cornerstone of the framework is based on a recurrent neural network architecture, the Generator. It seeks to learn the building rules of valid molecules to sample new compounds further. Also, two Predictors are trained to estimate the properties of interest of the new molecules. Finally, the fine-tuning of the Generator was performed with reinforcement learning, integrated with multi-objective optimization and exploratory techniques to ensure that the Generator is adequately biased. RESULTS: The biased Generator can generate an interesting set of molecules, with approximately 85% having the two fundamental properties biased as desired. Thus, this approach has transformed a general molecule generator into a model focused on optimizing specific objectives. Furthermore, the molecules’ synthesizability and drug-likeness demonstrate the potential applicability of the de novo drug design in medicinal chemistry. AVAILABILITY AND IMPLEMENTATION: All code is publicly available in the https://github.com/larngroup/De-Novo-Drug-Design. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2021-07-12 /pmc/articles/PMC8336597/ /pubmed/34252946 http://dx.doi.org/10.1093/bioinformatics/btab301 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Biomedical Informatics Pereira, Tiago Abbasi, Maryam Oliveira, José Luis Ribeiro, Bernardete Arrais, Joel Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title | Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title_full | Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title_fullStr | Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title_full_unstemmed | Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title_short | Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
title_sort | optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design |
topic | Biomedical Informatics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336597/ https://www.ncbi.nlm.nih.gov/pubmed/34252946 http://dx.doi.org/10.1093/bioinformatics/btab301 |
work_keys_str_mv | AT pereiratiago optimizingbloodbrainbarrierpermeationthroughdeepreinforcementlearningfordenovodrugdesign AT abbasimaryam optimizingbloodbrainbarrierpermeationthroughdeepreinforcementlearningfordenovodrugdesign AT oliveirajoseluis optimizingbloodbrainbarrierpermeationthroughdeepreinforcementlearningfordenovodrugdesign AT ribeirobernardete optimizingbloodbrainbarrierpermeationthroughdeepreinforcementlearningfordenovodrugdesign AT arraisjoel optimizingbloodbrainbarrierpermeationthroughdeepreinforcementlearningfordenovodrugdesign |